camptothecin has been researched along with cepharanthine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Andoh, T; Aogi, K; Fujiwara, Y; Hirabayashi, N; Kim, R; Kusano, T; Mizutani, A; Nishiyama, M; Okada, K; Sumiyoshi, H; Toge, T; Yamakido, M | 1 |
2 other study(ies) available for camptothecin and cepharanthine
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Overcoming CPT-11 resistance by using a biscoclaurine alkaloid, cepharanthine, to modulate plasma trans-membrane potential.
Topics: Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Benzylisoquinolines; Biological Transport; Camptothecin; Cell Membrane; Drug Interactions; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Irinotecan; Mammary Neoplasms, Experimental; Mice; Tumor Cells, Cultured | 1997 |